Business · 23/09/2011
FDA Clears Loxapine Succinate Capsules and Other Drug Products for Sale
The US Food and Drug Administration (FDA) has ruled that four drug products, including Loxapine Succinate capsules, were not withdrawn from the market due to safety or effectiveness concerns, allowing the FDA to continue approving new applications for these products.
Original source language: Federal Register — Health and Human ServicesOpen original release →